Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur, Founder and Chief Executive Officer, ...

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

Allurion Technologies said patients treated with its weight-loss program in a clinical study maintained higher muscle mass and had a bigger decrease in fat percentage. The developer of obesity ...

Shares of Allurion Technologies climbed after patients treated with its weight-loss program in a clinical study maintained higher muscle mass and had a bigger decrease in fat percentage.

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced the presentation of a study at the Societe Francaise et ...

The Zacks Medical - Products industry is expected to face growing uncertainty as the United States reimposes tariffs. Tariffs ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

As of the first quarter of 2025, Yale University (Trades, Portfolio)'s portfolio included two stocks. The top holdings were 98.1% in iShares Core S&P Total U.S. Stock Market ETF (ITOT) and 1.9% in ...

Allurion Technologies Inc. (ALUR) reported a notable decline in revenue for Q1 2025, with figures decreasing to $5.6 million from $9.4 million in the same period last year. Despite the revenue drop, ...

Hello, everyone, and welcome to Allurion First Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and ...